The Patent Finder

Pin Pharma, Inc.

Also on record
Records under this name other than patents Pin Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Pin Pharma, Inc.

PatentTitleStatus Expires Confidence
US 9,878,001Immunosuppressive Tat derivative polypeptides
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,927,580Tat-based immunomodulatory compositions and methods of their discovery and use
Term ended
Term ended Jul 7, 2026 · From the USPTO record
Term endedTerm ended Jul 7, 2026From the USPTO record
US 9,663,556Treatment of cancers with immunostimulatory HIV tat derivative polypeptides
Lapsed on the fee record
Ended May 30, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 30, 2025From the USPTO record
US 9,206,239Treatment of cancers with immunostimulatory HIV Tat derivative polypeptides
Lapsed on the fee record
Ended Dec 8, 2023 · From the USPTO record
Lapsed on the fee recordEnded Dec 8, 2023From the USPTO record
US 10,159,707Treatment of cancers with immunostimulatory HIV Tat derivative polypeptides
Lapsed on the fee record
Ended Dec 25, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 25, 2022From the USPTO record
US 8,530,431Treatment of cancers with immunostimulatory HIV TAT derivative polypeptides
Lapsed on the fee record
Ended Sep 10, 2021 · From the USPTO record
Lapsed on the fee recordEnded Sep 10, 2021From the USPTO record
US 6,667,151Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease
Term ended
Term ended Aug 10, 2020 · From the USPTO record
Term endedTerm ended Aug 10, 2020From the USPTO record
US 8,323,928Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease
Term ended
Term ended Aug 10, 2020 · From the USPTO record
Term endedTerm ended Aug 10, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited